The most well-studied therapies include conventional heart failure therapies, including angiotensin converting enzyme (ACE) inhibitors and beta blockers, and dexrazoxane; additionally, there are multiple investigational treatments currently undergoing evaluation. The gene discussed is ACE; the disease is heart failure.